新加坡博彩公司www.99cx.vip)是一个开放皇冠体育网址代理APP下载、皇冠体育网址会员APP下载、皇冠体育网址线路APP下载、皇冠体育网址登录APP下载的官方平台。新加坡博彩公司上最新新加坡博彩公司登录线路、新加坡博彩公司代理网址更新最快。新加坡博彩公司开放皇冠官方会员注册、皇冠官方代理开户等业务。

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

PARIS: Sanofi is ending development of a key cancer medicine in a blow to the French drugmaker’s pipeline of experimental therapies.

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

The move leaves Sanofi even more dependent for growth on blockbuster Dupixent, an antibody treatment for ailments ranging from asthma to severe eczema.

The company’s slate of experimental medicines has faced other setbacks, including safety concerns regarding multiple sclerosis treatment tolebrutinib.

,

新2网址最新登录www.99cx.vip)实时更新发布最新最快最有效的新2最新登录网址,包括新2手机网址,新2备用网址,皇冠最新网址,新2足球网址,新2网址大全。

,

Sanofi has included both amcenestrant and tolebrutinib as among six products in its pipeline that it prioritised as “potentially transformative” treatments.

Some investors are questioning the company’s growth trajectory after both of those medicines encountered problems.

UBS analysts last week downgraded Sanofi, saying there are few major catalysts coming soon to drive more excitement to the stock. — Bloomberg


转载说明:本文转载自Sunbet。 欧博开户声明:该文看法仅代表作者自己,与本平台无关。转载请注明:新2网址最新登录:Sanofi ends cancer drug trials
发布评论

分享到:

www.a55555.net(www.a55555.net):Maybank IB bags multiple awards at FinanceAsia Country Awards
1 条回复
  1. usdt无需实名交易(www.usdt8.vip)
    usdt无需实名交易(www.usdt8.vip)
    (2022-11-28 00:12:09) 1#

    Unbilled sales increased to RM3.4bil, compared with RM1.8bil in the same period last year, ensuring earnings visibility for the next two years.很亲切呢

发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。